InvestorsHub Logo
Followers 47
Posts 3929
Boards Moderated 0
Alias Born 03/04/2012

Re: None

Monday, 11/02/2020 12:15:46 AM

Monday, November 02, 2020 12:15:46 AM

Post# of 403025
I'm surprised no one noticed what's been missing from the last two press releases (Oct. 2 and Oct. 30, 2020).

The following statement, included in previous PRs before Oct. 2, was missing from these last two:

"For researchers and institutions interested in collaborating on Brilacidin for COVID-19, please send inquiries to: covid19@ipharminc.com"

This suggests that Leo has plenty of interest on his plate and doesn't need to solicit more.

With a Selectivity Index of 426 for Brilacidin against Covid-19, the interest will only increase.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News